Management of threatening preterm labor with intact membranes: Indications for antibiotics;Prise en charge de la menace d'accouchement prématuré à membranes intactes: Indication des antibiotiques

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 31, Issue 7 SUPPL., 2002, Pages

  Winer, N ^a  

^a Hopital Mere Enfant CHU de Nantes   (France)

Author keywords

Acquired bacterial resistance; Prematurity; Preterm labor; Systematic antibiotherapy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CLINDAMYCIN; MACROLIDE; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; ASYMPTOMATIC BACTERIURIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CREAM; DRUG INDICATION; HIGH RISK POPULATION; HUMAN; LOCAL THERAPY; MEDLINE; META ANALYSIS; MOTHER FETUS RELATIONSHIP; NEWBORN SEPSIS; PREMATURE LABOR; PRESCRIPTION; REVIEW; RISK BENEFIT ANALYSIS; VAGINA PESSARY;

ANTI-BACTERIAL AGENTS; EXTRAEMBRYONIC MEMBRANES; FEMALE; FRANCE; HUMANS; MYCOPLASMA INFECTIONS; OBSTETRIC LABOR, PREMATURE; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TREATMENT OUTCOME; VAGINOSIS, BACTERIAL;

EID: 0036859164     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Pons G, Rey E. Antibiothérapie et grossesse. In: Obstétrique, Papiernick E, Cabrol D, Pons JC, ed Flammarion, 1995: 779-83.
2. Vigneswaran R. Infection and preterm birth: Evidence of a common causal relationship with bronchopulmonary dysplasia and cerebral palsy. J Paediatr Child Health 2000; 36: 293-6.
3. Berkowitz G, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 1993; 15: 414-43.
4. O'Shea TM, Klinepeter KL, Mels PJ, Dillard RG. Intrauterine infection and the risk of cerebral palsy in very low birthweight infants. Paediatr Perinat Epidemiol 1998; 12: 72-83.
5. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182: 675-81.
6. Bass WT, Jones MA, White LE, Montgomery TR, Aiello F 3rd, Karlowicz MG. Ultrasonographic differential diagnosis and neurodevelopmental outcome of cerebral white matter lesions in premature infants. J Perinatol 1999; 19: 330-6.
7. Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA 2000; 284: 2996-7.
8. Fernandez H, Ville Y, Bourget P. Antibioprophylaxie en Obstétrique. Med Mal Inf 1994; 24: 1123-36.
9. Guzick DS, Winn K. The association of chorioamnionitis with preterm delivery. Obstet Gynecol 1985; 65: 11-6.
10. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342: 1500-7.
11. Romero R, Gomez R, Chaiworapongsa T, Conoscenti G, Kim JC, Kim YM. The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol 2001; 15 (Suppl 2): 41-56.
12. McGregor JA, French JI, SeoK. Adjunctive clindamycin therapy for preterm labor: Results of a double-blind placebo-controlled trial. Am J Obstet Gynecol 1991; 166: 867-75.
13. Norman K, Pattinson RC, de Souza J, de Jong P, Moller G, Kirsten G. Ampicillin and metronidazole treatment in preterm labour: A multicentre, randomised controlled trial. Br J Obstet Gynaecol 1994; 101: 404-8.
14. Newton ER, Dinsmoor MJ, Gibbs RS. A randomized, blinded, placebo-controlled trial of antibiotics in idiopathic preterm labour. Obstet Gynecol 1989; 74: 562-6.
15. Romero R, Sibai B, Caritis S, Paul R, Depp R, Rosen M, et al. Antibiotic treatment of preterm labor with intact membranes: A multicenter, randomized, double blinded, placebo-controlled trial. Am J Obstet Gynecol 1993; 1691: 764-74.
16. ANAES. Prévention Anténatale du Risque Infectieux Bactérien Néonatal Précoce: Recommandations pour la Pratique Clinique, septembre 2001. http://www.anaes.fr
17. Nadisauskiene R, Bergstrom S, Kilda A. Ampicillin in the treatment of preterm labor: A randomised placebo-controlled study. Gynecol Obstet Invest 1996; 41: 89-92.
18. Svare J, Langhoff-Roos J, Andersen LF, Kryger-Baggesen N, Borch-Christensen H, Heisterberg L, et al. Ampicillin-metronidazole treatment in idiopathic preterm labour: A randomised controlled multicentre trial. Br J Obstet Gynaecol 1997; 104: 892-7.
19. Thorp JM, Hartmann KE, Bezrkman ND, Carey TS, Lohr KN, Gavin NI, et al. Antibiotic therapy for the treatment of preterm labor: A review of the evidence. Am J Obstet Gynecol 2002; 186: 587-92.
20. King J, Flenady V. Antibiotics for preterm labour with intact membranes. The Cochrane Library 2002, issue 2, 1-12.
21. Gordon M, Samuels P, Shubert P, Johnson F, Gebauer C, lams J. A randomized, prospective study of adjunctive ceftizoxime in preterm labor. Am J Obstet Gynecol 1995; 172: 1546-52.
22. Reimer T, Ulfig N, Friese K. Antibiotics: Treatment of preterm labor. J Perinat Med 1999; 27: 35-40.
23. Locksmith G, Duff P. Infection, antibiotics, and preterm delivery. Semin Perinatol 2001; 25: 295-309.
24. Oyarzun E, Gomez R, Rioseco A, Gonzalez P, Gutierrez P, Donoso E, Montiel F. Antibiotic treatment in preterm labor and intact membranes: A randomized, double-blinded, placebo-controlled trial. J Matern Fetal Med 1998; 7: 105-10.
25. Kenyon SL, Taylor DJ, Tarnow-Mordi W, and ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: The ORACLE II randomised trial. Lancet 2001; 357: 989-94.
26. McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: Results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994; 1701: 1048-60.
27. Rosenstein IJ, Morgan DJ, Lamont RF, Sheehan M, Dore CJ, Hay PE, et al. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol 2000; 6: 158-65.
28. Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: A randomized, controlled trial. Obstet Gynecol 2001; 97: 643-8.
29. Vermeulen GM, van Zwet AA, Bruinse HW. Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous preterm birth. Br J Obstet Gynaecol 2001; 108: 697-700.
30. Vermeulen GM, Bruinse HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: A randomised placebo-controlled double-blind trial. Br J Obstet Gynaecol 1999; 106: 652-7.
31. Kurkinen-Raty M, Vuopala S, Koskela M, Kekki M, Kurki T, Paavonen J, et al. A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. Br J Obstet Gynaecol 2000; 107: 1427-32.
32. Hay PE, Morgan DJ, Ison CA, Bhide SA, Romney M, McKenzie P, et al. A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol 1994; 101: 1048-53.
33. Subtil D, Denoit V, Goueff FL, Husson MO, Trivier D, Puech F. The role of bacterial vaginosis in preterm labor and preterm birth: A case-control study. Eur J Obstet Gynecol Reprod Biol 2002; 101: 41-6.
34. Flynn CA, Helwig AL, Meurer LN. Bacterial vaginosis in pregnancy and the risk of prematurity: A meta-analysis. J Fam Pract 1999; 48: 885-92.
35. Morales WJ, Schorr S, Albritton J. Effects of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: A placebo controlled, double bind study. Am J Obstet Gynecol 1994; 171: 348-9.
36. McGregor JA, Roberts AM. First antenatal visits and metronidazole. Am J Obstet Gynecol 1997; 176: 887-8.
37. Brocklehurst P, Hannah M, McDonald H. Interventions for treating bacterial vaginosis in pregnancy. In: The Cochrane Library, 2002, Issue 2.
38. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000; 342: 534-40.
39. Caro-Paton T, Carvajal A, Martin de DI, Martin-ALH, Alvarez Requejo A, Rodriguez PE. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997; 44: 179-82.
40. Schwebke JR. Metronidazole: Utilization in the obstetric and gynecologic patient. Sex Transm Dis 1995; 22: 370-6.
41. Antsaklis A, Daskalakis G, Michalas S, Aravantinos D. Erythromycin treatment for subclinical Ureaplasma urealyticum infection in preterm labor. Fetal Diagn Ther 1997; 12: 89-92.
42. Carey JC, Blackwelder WC, Nugent RP, Matteson MA, Rao AV, Eschenbach DA, et al. Antepartum cultures for ureaplasma urealyticum are not useful in predicting pregnancy outcome. The vaginal infections and prematurity study group. Am J Obstet Gynecol 1991; 164: 728-33.
43. Eschenbach DA, Nugent RP, Rao AV, Cotch MF, Gibbs RS, Lipscomb KA, et al. A randomised placebo-controlled trial of erythromycin for the treatment of ureaplasma urealyticum to prevent premature delivery. The vaginal infections and prematurity study group. Am J Obstet Gynecol 1991; 164: 734-42.
44. Ogasawara KK, Goodwin TM. Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. J Matern Fetal Med 1999; 8: 12-16.
45. Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines 1993; 42: 47-56.
46. Gencay M, Koskiniemi M, Saikku P, Puolakkainen M, Raivio K, Koskela P, et al. Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infect Dis 1995; 21: 424-6.
47. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986; 256: 1899-903.
48. Claman P, Toye B, Peeling RW, Jessamine P, Belcher J. Serologic evidence of Chlamydia trachomatis infection and risk of preterm birth. Can Med Assoc J 1995; 153: 259-62.
49. McGregor JA, French JI, Richter R, Vuchetich M, Bachus V, Seo K, et al. Cervicovaginal microflora and pregnancy outcome: Results of a double-blind, placebo-controlled trial of erythromycin treatment. Am J Obstet Gynecol 1990; 163: 1580-91.
50. Judlin P, Terville JP. Traitement curatif et préventif des infections cervico-vaginales. J Gynecol Obstet Biol Reprod 1997, 26: 38-41.
51. Towers CV, Bpharm GGB. Antepartum use of antibiotics and early-onset neonatal sepsis: The next 4 years. Am J Obstet Gynecol 2002; 187: 495-500.
52. Joseph TA, Pyati SP, Jacobs N. Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. Arch Pediatr Adolesc Med 1998; 152: 35-40.
53. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter casecontrol study. Pediatrics 2000; 105: 21-6.
54. Mercer BM, Carr TL, Beazley DD, Crouse DT, Sibai BM. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol 1999; 181: 816-21.
55. Mittendorf R, Williams MA, Kass EH. Prevention of preterm delivery and low birth weight associated with asymptomatic bacteriuria. Clin Infect Dis 1992; 14: 927-32.
56. Kiningham RB. Asymptomatic bacteriuria in pregnancy. Am Fam Physician 1993; 47: 1232-8.
57. Cram LF, Zapata MI, Toy EC, Baker B 3rd. Genitourinary infections and their association with preterm labor. Am Fam Physician 2002; 65: 241-8.
58. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. In: The Cochrane Database Syst Rev, Issue 2; 2001.
59. Conférence de consensus. Société de Pathologie Infectieuse de Langue Française (SPILF). Med Mai Inf 1991; 21: 51-4.
60. Villar J, Lydon-Rochelle MT, Gulmezoglu AM, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. In: The Cochrane Database Syst Rev, Issue 2, 2000.
61. Reeves DS. Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: A review. Infection 1992; 20: 313-6.
62. Christensen B. Which antibiotics are appropriate for treating bacteriuria in pregnancy? J Antimicrob Chemother 2000; 46: 29-34.